According to an expert at AL Sydbank, Amycretin, which will certainly currently be checked in stage III tests, is among one of the most vital prospects in Novo Nordisk’s late-stage pipe.
发布者:BY Christopher Karlsson,转转请注明出处:https://robotalks.cn/novo-nordisk-launches-crucial-trial-with-weight-loss-hope/